Eli Lilly is further delving into the radiopharmaceutical field with a $140 million upfront deal with Radionetics Oncology.
The strategic pact with the San Diego …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.